Named PRIMA, the device may help those with advanced dry age-related macular degeneration get improvements in their eyesight. The company is in talks to also conduct trials in the United States.

Macular degeneration is the most common cause of age-related vision loss in older adults. In a healthy eye, light travels through the pupil and hits the retina, the inner back layer of your eye.

Macular degeneration usually refers to the age-related degenerative changes in the retina that can result in loss of central vision. It is caused by abnormal blood vessel growth (a condition ...

With wet AMD, abnormal blood vessels grow under the macula. The wet form of age-related macular degeneration can start suddenly. You won’t feel pain, but you might notice vision problems.

Doctors have taken a major step towards curing the most common form of blindness in the UK - age-related macular degeneration ... their affected eye at all, to reading 60 to 80 words per minute.

If you receive a diagnosis for macular degeneration, daily tasks like reading, cooking, and driving often become more ...

Age-related macular degeneration (AMD ... making everyday activities like reading and recognizing faces difficult. There are two main types: dry (atrophic) AMD and wet (neovascular) AMD.

Macular degeneration, also known as age-related macular degeneration (AMD), is the most common form of vision loss in older ...

Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...

The European Medicines Agency (EMA) has announced its approval of two new biosimilar medications, Afqlir and Opuviz, to treat age-related macular degeneration (ARMD). The active ingredient of both ...